KDR and cancer: The expression of VEGFR-2 in human and murine cell lines was measured with western blotting to assess functional VEGFR-2 signalling and susceptibility to vandetanib and similar TKIs, both of which have implications for cancer growth and vandetanib treatment (Figure 1).